Related articles:

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2016 Fourth Quarter and Full Year Financial Results
March 03, 2017
March 3, 2017

Lexicon Pharmaceuticals Inc.: Lexicon to Report Fourth Quarter and Year End 2016 Financial Results on March 3, 2017
March 01, 2017
March 1, 2017

Lexicon Pharmaceuticals Inc.: Lexicon to Report Third Quarter 2016 Financial Results on November 1, 2016
October 25, 2016
October 25, 2016

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Announces Agreement to Buy out Remaining Obligations to Symphony Icon
October 05, 2016
October 5, 2016

Lexicon Pharmaceuticals Inc.: Lexicon Reports Positive Top-line Results in Pivotal Phase 3 Study for Sotagliflozin in Patients with Type 1 Diabetes
September 09, 2016
September 9, 2016

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2016 Second Quarter Financial Results
August 04, 2016
August 4, 2016

Lexicon Pharmaceuticals Inc.: Lexicon to Report Second Quarter 2016 Financial Results on August 4, 2016
August 01, 2016
August 1, 2016

Lexicon Pharmaceuticals Inc.: Lexicon to Present at the Cantor Fitzgerald Healthcare Conference
July 07, 2016
July 7, 2016

Lexicon Pharmaceuticals Inc.: Lexicon to Present at the Jefferies 2016 Healthcare Conference
June 06, 2016
June 6, 2016

Lexicon Pharmaceuticals Inc.: Praveen Tyle, Ph.d. Joins Lexicon as Executive Vice President of Research and Development
May 09, 2016
May 9, 2016

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2016 First Quarter Financial Results
May 02, 2016
May 2, 2016

Lexicon Pharmaceuticals Inc.: Lexicon to Report First Quarter 2016 Financial Results on May 3, 2016
April 29, 2016
April 29, 2016

Lexicon Pharmaceuticals Inc.: Lexicon to Report Fourth Quarter and Year End 2015 Financial Results on March 1, 2016
February 25, 2016
February 25, 2016

Lexicon Pharmaceuticals Inc.: Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes
November 06, 2015
November 6, 2015

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results and Discusses Collaboration with Sanofi for Sotagliflozin
November 06, 2015

Lexicon Pharmaceuticals Inc.: Lexicon to Report Third Quarter 2015 Financial Results on November 6, 2015
November 05, 2015
November 5, 2015

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update
August 07, 2015
August 7, 2015

Lexicon Pharmaceuticals Inc.: Lexicon to Report Second Quarter 2015 Financial Results on August 7, 2015
August 05, 2015
August 5, 2015

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2015 First Quarter Financial Results
April 29, 2015
April 29, 2015

Lexicon Pharmaceuticals Inc.: Lexicon to Report First Quarter 2015 Financial Results on April 29, 2015
April 27, 2015
April 27, 2015

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance
April 15, 2015
April 15, 2015

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2014 Fourth Quarter and Full Year Financial Results
March 03, 2015
March 3, 2015

Lexicon Pharmaceuticals Inc.: Lexicon to Report Fourth Quarter and Year End 2014 Financial Results on March 4, 2015
March 02, 2015
March 2, 2015

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2014 Third Quarter Financial Results
November 04, 2014
November 4, 2014

Lexicon Pharmaceuticals Inc.: Lexicon to Report Third Quarter 2014 Financial Results on November 4, 2014
November 03, 2014
November 3, 2014

Lexicon Pharmaceuticals Inc.: Lexicon and Ipsen Enter into Ex-North America/Japan Licensing and Commercialization Agreement for Telotristat Etiprate
October 21, 2014
October 21, 2014

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2014 Second Quarter Financial Results
August 07, 2014
August 7, 2014

Lexicon Pharmaceuticals Inc.: Lexicon to Report Second Quarter 2014 Financial Results on August 7, 2014
August 05, 2014
August 5, 2014

Lexicon Pharmaceuticals Inc.: Lexicon and JDRF Collaborate for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
July 09, 2014
July 9, 2014

Lexicon Pharmaceuticals Inc.: Lexicon and JDRF Collaborate for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
July 08, 2014
July 8, 2014

Lexicon Pharmaceuticals Inc.: Lexicon Announces Appointment of Lonnel Coats as President and Chief Executive Officer
July 07, 2014
July 7, 2014

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2014 First Quarter Financial Results
May 07, 2014
May 7, 2014

Lexicon Pharmaceuticals Inc.: Lexicon to Report First Quarter 2014 Financial Results on May 8, 2014
May 04, 2014
May 4, 2014

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 Fourth Quarter and Full Year Financial Results
February 27, 2014
February 27, 2014

Lexicon Pharmaceuticals Inc.: Lexicon to Report Fourth Quarter and Year End 2013 Financial Results on February 28, 2014
February 20, 2014
February 20, 2014

Lexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 Third Quarter Financial Results
November 11, 2013
November 11, 2013

Pin It on Pinterest

Share This